02 November 2022 |
| 08:50-09:00 | | Welcome and Introduction Chair(s): Dinesh Giri, BSPED CME Officer (Bristol, UK) Hall 1A
|
| 09:00-10:00 | | CME Session 1 Chair(s): Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK) Hall 1A
|
| 09:00 | | Endocrine approach of a patient with late effects |
| 09:30 | | Genetic approach to short stature |
| 10:00-10:30 | | CME Case Presentations 1 Chair(s): Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK) Hall 1A
|
| 10:15 | OC1.1 | Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction |
| 10:00 | OC1.2 | A rare case of short stature with high total Insulin Like Growth Factor 1 (IGF-1) and a novel pregnancy-associated plasma protein A2 (PAPPA2) gene mutation |
| 10:30-11:00 | | Break Hall 1C & 1D
|
| 11:00-12:00 | | CME Session 2 Chair(s): Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK) Hall 1A
|
| 11:00 | | Neonatal Diabetes |
| 11:30 | | An approach to hypo/hypercalcemia |
| 12:00-12:30 | | CME Case Presentations 2 Chair(s): Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK) Hall 1A
|
| 12:00 | OC2.1 | Coeliac disease presenting with anti-OPG antibody mediated childhood osteoporosis and response to bisphosphonate therapy |
| 12:15 | OC2.2 | The missing segment from the age of enlightenment |
| 12:30-12:40 | | CSAC Trainee Representative Update Chair(s): Katherine Hawton (Bristol, UK) & Rachel Boal (Newcastle, UK) Hall 1A
|
| 12:40-13:30 | | Lunch Hall 1C & 1D
|
| 13:30-14:30 | | CME Session 3 Chair(s): Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK) Hall 1A
|
| 13:30 | | Estrogen replacement in girls with Primary ovarian insufficiency |
| 14:00 | | Approach to hypogonadism in adolescent boys |
| 14:30-15:00 | | CME Case Presentations 3 Chair(s): Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK) Hall 1A
|
| 14:30 | OC3.2 | Two cases on the Carney Complex spectrum secondary to PRKACA/PRKAR1A variants presenting with Cushing Syndrome in childhood |
| 14:45 | OC3.1 | A rare form of ovotesticular difference of sex development (DSD) in combination with severe early-onset obesity due to MC4R mutation: Clinical features and diagnostic challenges |
| 15:00-15:30 | | Break Hall 1C & 1D
|
| 15:30-16:00 | | CME Session 4 Chair(s): Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK) Hall 1A
|
| 15:30 | | An approach to dynamic stimulation tests with challenges and pitfalls |
| 16:00-16:30 | | CME Case Presentations 4 Chair(s): Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK) Hall 1A
|
| 16:00 | OC4.1 | Pseudohypoaldosteronism case series |
| 16:15 | OC4.2 | Treatment-induced neuropathy of diabetes: A case report |
| 16:30-16:45 | | CME Officer's Update & Conclusion Chair(s): Dinesh Giri (Bristol, UK) Hall 1A
|
| 17:00-18:00 | | Industry Sponsored Satellite Symposium For more information please refer to the Industry Sponsored Programme Hall 1A
|
| 17:00-18:00 | | Industry Sponsored Satellite Symposium For more information please refer to the Industry Sponsored Programme Hall 1B
|
| 18:00-19:00 | | Welcome Reception Hall 1C & 1D
|
03 November 2022 |
| 08:00-08:45 | | Industry Sponsored Satellite Symposium For more information please refer to the Industry Sponsored Programme Hall 1A
|
| 08:45-09:00 | | Break Hall 1C & 1D
|
| 09:00-09:10 | | Welcome and Introduction Chair(s): Tabitha Randell, Nottingham (BSPED President) Senthil Senniappan, Liverpool (POC Chair) Noina Abid, Belfast (Local Convenor) Hall 1A
|
| 09:10-10:40 | | Endocrine Oral Communications 1 Chair(s): Charlotte Elder (Sheffield, UK) & Evelien Gevers (London, UK) Hall 1A
|
| 09:10 | OC5.1 | Can lymphocyte subsets and B cell cytokines predict clinical response to Rituximab in paediatric Graves’ disease? |
| 09:20 | OC5.2 | Central Delayed puberty in Adolescence: Differentiating the phenotypes of Congenital Hypogonadotropic Hypogonadism and Self-Limited Delayed Puberty. |
| 09:30 | OC5.3 | UK Protocol for Induction of Puberty with Gonadotropins in Males with Hypogonadotropic Hypogonadism |
| 09:40 | OC5.4 | Greater Postnatal Adiposity Gain Following Inadequate Fetal Growth in The Manchester BabyGRO Study |
| 09:50 | OC5.5 | The lack of genotype:phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testing |
| 10:00 | OC5.6 | Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rate |
| 10:10 | OC5.7 | Salivary Cortisol and Cortisone in Healthy Children and Young People |
| 10:20 | OC5.8 | SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiency |
| 10:30 | OC5.9 | Evaluation Of A Low Postnatal Hypoglycaemia Threshold |
| 09:10-10:40 | | Diabetes and Covid Symposium Chair(s): Tony Hulse (London, UK) & Rachel Besser (Oxford, UK) Hall 1B
|
| 09:10 | | Introduction and the South East Thames Study |
| 09:20 | | ‘DIMPLES’: Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: a multicentre retrospective observational study |
| 09:40 | | ‘DIMPLES’: the Irish dimension |
| 09:50 | | ‘Proving Causation?’: antibody studies in Covid related Diabetes |
| 10:00 | | Obesity and Type 2 diabetes and Covid |
| 10:15 | | 'What does all this mean?’ A panel discussion and Q&A session including Dr. Colin Dayan and chaired by Dr.Rachel Besser |
| 09:10-10:40 | | Endocrine Nurses' Business Meeting Chair(s): Lee Martin (London, UK) & Angela McCormick (Belfast, UK) Meeting Room 1
|
| 10:40-11:10 | | Break Hall 1C & 1D
|
| 11:10-12:10 | | Endocrine Symposium 1 Chair(s): Renuka Dias (Birmingham, UK) & Pooja Sachdev (Nottingham, UK) Hall 1A
|
| 11:10 | | Congenital Imprinting Disorders |
| 11:40 | | Consensus Guidelines for the management of Grave's diesease |
| 11:10-12:10 | | Diabetes Symposium 2 Chair(s): Anuja Natarajan (Doncaster, UK) & Noina Abid (Belfast, Northern Ireland) Hall 1B
|
| 11:10 | | Impact of Diabetes Ketoacidosis on glycaemic control |
| 11:40 | | The big fat question - lipids and glycaemia |
| 12:10-12:40 | | Endocrine Oral Communications 2 Chair(s): Christina Wei (London, UK) & Catherine Peters (London, UK) Hall 1A
|
| 12:10 | OC6.1 | Pubertal staging examinations: A national survey of current practice in consent and chaperone use |
| 12:16 | OC6.2 | The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in The Manchester BabyGRO Study |
| 12:22 | OC6.3 | Use of 24 weekly Decapeptyl SR in Central Precocious Puberty is Well-Tolerated and Efficacious – A Two Centre Study |
| 12:28 | OC6.4 | A Collaborative Community based Approach in providing Support for Children and Young People with Severe Obesity |
| 12:34 | OC6.5 | Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal Hyperplasia |
| 12:10-12:40 | | Diabetes Oral Communications 1 Chair(s): Melanie Kershaw (Birmingham, UK) & Fiona Campbell (Leeds, UK) Hall 1B
|
| 12:10 | OC7.1 | Comparison of outcomes of the hybrid closed loop therapy with the conventional insulin pump in the first year after pump initiation |
| 12:16 | OC7.2 | Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus |
| 12:22 | OC7.5 | Monogenic obesity is probably not so rare - experience from a large tier 3 paediatric weight management service |
| 12:28 | OC7.4 | Type A insulin resistance syndrome presenting with PCOS features and an unusual pattern of diabetes in a 10-year-old female |
| 12:34 | OC7.3 | Hypogonadism and pubertal disorders in Wolfram Syndrome |
| 12:40-13:10 | | Industry Sponsored Expert Insights Session For more information please refer to the Industry Sponsored Programme Hall 1A
|
| 12:40-13:10 | | Industry Sponsored Expert Insights Session For more information please refer to the Industry Sponsored Programme Hall 1B
|
| 13:10-14:10 | | Lunch and Poster Tours Hall 1C & 1D
|
| 14:10-14:40 | | Awards Session - James M Tanner Award Chair(s): Tabitha Randell (Nottingham, UK) Hall 1A
|
| 14:10 | | New abstract |
| 14:40-15:40 | | Diabetes Symposium 3 Chair(s): Toby Candler (Bristol, UK) & Tabitha Randell (Nottingham, UK) Hall 1B
|
| 14:40 | | Screening for Type 1 Diabetes - the ELSA study |
| 15:10 | | Immunotherapy in diabetes - preservation of beta cells |
| 14:40-15:40 | | Endocrine Symposium 2 Chair(s): Shankar Kanumakala (Brighton, UK) & Senthil Senniappan (Liverpool, UK) Hall 1A
|
| 14:40 | | BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young people |
| 15:10 | | UK Consensus Guidelines for Hyperinsulinism Management |
| 15:40-15:50 | | Break Hall 1C & 1D
|
| 15:50-16:50 | | Personal Practice Session Chair(s): Ved Bhushan Arya (London, UK) & Bindu Avatapalle (Cardiff, UK) Hall 1B
|
| 15:50 | | Long acting growth hormone |
| 16:20 | | Structured education programme for Type 1 Diabetes in Northern Ireland |
| 15:50-16:20 | | Endocrine Oral Communications 3 Chair(s): Ritika Kapoor (London, UK) & Tim Cheetham (Newcastle, UK) Hall 1A
|
| 15:50 | OC8.1 | Do we need earlier thyroid surveillance amongst PTEN patients in the UK? |
| 15:56 | OC8.2 | Endocrine Effects of MEK and BRAF Inhibitor Therapy in Paediatric Patients: A Tertiary Centre Experience |
| 16:02 | OC8.3 | Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth gene |
| 16:08 | OC8.4 | A national survey of bone-endocrine monitoring in Duchenne muscular dystrophy and the patients’ experience |
| 16:14 | OC8.5 | Contrast media-induced hypothyroidism |
| 17:00-18:00 | | AGM (BSPED members only) Hall 1A
|
| 19:30-00:00 | | Conference Dinner Belfast City Hall
|
04 November 2022 |
| 09:30-11:00 | | Diabetes Symposium 4 Chair(s): Nicola Bridges (London, UK) & Louise Denvir (Nottingham, UK) Hall 1A
|
| 09:30 | | Interpreting continuous glucose monitoring |
| 10:00 | | Interpreting close loop pump downloads |
| 10:30 | | Developing an early stage treatment for diabetic retinopathy |
| 09:30-11:00 | | Nurses' Day for Endocrine Professionals (Endocrine Symposium 3) Chair(s): Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK) Hall 1B
|
| 09:30 | | CAH & Adolescent gynaecology – an MDT perspective |
| 10:30 | | CAH and adolescence - a parent's perspective |
| 11:00-11:30 | | Break Hall 1C & 1D
|
| 11:30-13:00 | | Diabetes Oral Communications 2 Chair(s): Mark Burns (Middleborough, UK) & Suma Uday (Birmingham, UK) Hall 1A
|
| 11:30 | OC9.1 | Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not |
| 11:40 | OC9.2 | Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for Wales |
| 11:50 | OC9.3 | Diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using UK electronic health records |
| 12:00 | OC9.4 | Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics? |
| 12:10 | OC9.5 | Raising Awareness of the Importance of Preconception Counselling in Young People with Diabetes |
| 12:20 | OC9.6 | A review of patient outcomes and responses to weight management strategies used by Complications from Excess Weight service, a new paediatric, hospital-based weight management service |
| 12:30 | OC9.7 | Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service |
| 12:40 | OC9.8 | Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using Continuous Glucose Monitoring |
| 11:30-12:30 | | Nurses' Day for Endocrine Professionals (Oral Communications 4) Chair(s): Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK) Hall 1B
|
| 11:30 | OC10.1 | Hormone Replacement Therapy in Paediatric Turner Syndrome – Evaluation of Current Practice in a Dedicated Paediatric Turner Clinic and Subsequent Development of Patient Resources |
| 11:40 | OC10.2 | Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiency |
| 11:50 | OC10.4 | Increasing Patient Adherence and reducing Drug Wastage: impact of a Personalised Patient Support Programme integrated with a digital connect ecosystem |
| 12:00 | OC10.5 | Factors affecting the hypoglycaemic response in the Insulin Tolerance Test in paediatric patients |
| 12:10 | OC10.6 | A comparative study observing the association between Graves’ disease and the Covid-19 pandemic in children |
| 12:20 | OC10.3 | Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders |
| 12:30-13:00 | | Presentations from Previous Award Winners Chair(s): Li Chan (London, UK) & Nadia Amin (Leeds, UK) Hall 1B
|
| 12:30 | | Bone health in Type 1 Diabetes: The Key Determinants of Skeletal Fragility and the Role of Metformin |
| 13:00-13:45 | | Lunch and Poster Tours Hall 1C & 1D
|
| 13:45-14:15 | | Industry Sponsored Expert Insights Session For more information please refer to the Industry Sponsored Programme Hall 1A
|
| 14:15-15:45 | | Diabetes Symposium 5 Chair(s): David McGregor (Devon, UK) & Zainaba Mohamed (Birmingham, UK) Hall 1A
|
| 14:15 | | Conflict & Collaboration in Diabetes Management |
| 14:45 | | Diabetes in toddlers - practicalities and challenges |
| 15:15 | | How to create and adapt exercise plans when using Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery Systems (AID) with type 1 diabetes |
| 14:15-15:45 | | Nurses' Day for Endocrine Professionals (Endocrine Symposium 4) Chair(s): Martha Ford-Adams (London, UK) & Mars Skae (Manchester, UK) Hall 1B
|
| 14:15 | | Immune dysregulation driving future risk of disease in children with obesity |
| 14:45 | | Non-alcoholic fatty liver disease |
| 15:15 | | Paediatric Endocrinology in Art |
| 15:45-16:00 | | BSPED 2022 Awards Session Chair(s): Senthil Senniappan (Liverpool, UK) & Nadia Amin (Leeds, UK) Hall 1A
|
| 16:00-16:15 | | Close of Meeting Chair(s): Senthil Senniappan, POC Chair (Liverpool, UK) Hall 1A
|